BioMed Realty Trust, Inc. (BMR) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Join SI Premium – FREE
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q4 EPS of $0.28, $0.01 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $112.4 million versus the consensus estimate of $112.02 million.
For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.
For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- e.l.f. Beauty, Inc. (ELF) Tops Q2 EPS by 64c, Beats on Revenue; Offers FY27 Guidance
- Zillow Group, Inc. (ZG) Misses Q3 EPS by 4c
- Acadia Pharma (ACAD) Tops Q3 EPS by 11c, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
